Vaishali Pharma allots shares to Kesar Pharma via share swap for 26.95% acquisition

Fund Raising View source PDF Explain this filing

VAISHALI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.7%Reaction day

₹7.30

prior close

₹7.57

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+2.5% vs market

Pharmaceuticals peers, median of 164sector-0.5%+3.3% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 3.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.6

10m

-3.6

15m

-2.9

30m

-2.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.7+0.2+2.5-0.5+3.3

Next day

+1.9-0.5+2.4-0.7+2.6

-0.8-2.5+1.7-1.7+0.9

-1.4-0.6-0.7-1.2-0.1

+3.6+0.7+2.8-0.5+4.0

+8.6+0.9+7.8+0.2+8.4

+7.5+0.5+7.0+0.4+7.1

15d

+6.0-0.2+6.3-1.4+7.5

+8.2+2.9+5.3-1.7+9.9

+14.9+5.0+10.0+1.2+13.7

+12.7+3.7+9.0+0.4+12.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vaishali Pharma allotted 45,37,865 equity shares at Rs. 20 each (total Rs. 9.08 crore) to Kesar Pharma Limited (KPL) on a preferential basis as non-cash consideration for acquiring 26.95% stake in KPL through a share swap. Post allotment, KPL holds 3.36% in Vaishali Pharma. Paid-up equity capital increased from Rs. 26.09 crore to Rs. 27 crore across about 13.50 crore shares.

Likely market impact

Share-swap acquisition of 26.95% in KPL causes about 3.5% equity dilution for existing holders; non-cash deal preserves company liquidity.